INTRODUCTION: Monoallelic variants in the ALG5 gene encoding asparagine-linked glycosylation protein 5 homolog (ALG5) have been recently shown to disrupt polycystin-1 (PC1) maturation and trafficking via underglycosylation, causing an autosomal dominant polycystic kidney disease-like (ADPKD-like) phenotype and interstitial fibrosis. In this report, we present clinical, genetic, histopathologic, and protein structure and functional correlates of a new ALG5 variant, p.R79W, that we identified in 2 distant genetically related Irish families displaying an atypical late-onset ADPKD phenotype combined with tubulointerstitial damage. METHODS: Whole exome and targeted sequencing were used for segregation analysis of available relatives. This was followed by immunohistochemistry examinations of kidney biopsies, and targeted (UMOD, MUC1) and untargeted plasma proteome and N-glycomic studies. RESULTS: We identified a monoallelic ALG5 variant [GRCh37 (NM_013338.5): g.37569565G>A, c.235C>T; p.R79W] that cosegregates in 23 individuals, of whom 18 were clinically affected. We detected abnormal localization of ALG5 in the Golgi apparatus of renal tubular cells in patients' kidney specimens. Further, we detected the pathological accumulation of uromodulin, an N-glycosylated glycosylphosphatidylinositol (GPI)-anchored protein, in the endoplasmic reticulum (ER), but not mucin-1, an O- and N-glycosylated protein. Biochemical investigation revealed decreased plasma and urinary uromodulin levels in clinically affected individuals. Proteomic and glycoproteomic profiling revealed the dysregulation of chronic kidney disease (CKD)-associated proteins. CONCLUSION: ALG5 dysfunction adversely affects maturation and trafficking of N-glycosylated and GPI anchored protein uromodulin, leading to structural and functional changes in the kidney. Our findings confirm ALG5 as a cause of late-onset ADPKD and provide additional insight into the molecular mechanisms of ADPKD-ALG5.

Department of Medicine Royal College of Surgeons in Ireland Dublin Ireland

Department of Nephrology and Transplantation Beaumont Hospital Dublin Ireland

Department of Nephrology Transplant Center Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Pathology Beaumont Hospital Dublin Ireland

Department of Pediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University Prague Prague Czech Republic

Department of Radiology Beaumont Hospital and Royal College of Surgeons in Ireland Dublin Ireland

Institute of Medical Biochemistry and Laboratory Diagnostics of the General University Hospital and of The 1st Faculty of medicine of Charles University Prague Prague Czech Republic

Institute of Microbiology The Czech Academy of Sciences Vestec Czech Republic

Research Unit for Rare Diseases Department of Pediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University Prague Prague Czech Republic

School of Pharmacy and Biomolecular Sciences Royal College of Surgeons Dublin Ireland

Section on Nephrology Wake Forest School of Medicine Winston Salem North Carolina USA

Zobrazit více v PubMed

Bergmann C., Guay-Woodford L.M., Harris P.C., Horie S., Peters D.J.M., Torres V.E. Polycystic kidney disease. Nat Rev Dis Primers. 2018;4:50. doi: 10.1038/s41572-018-0047-y. PubMed DOI PMC

Benson K.A., Murray S.L., Senum S.R., et al. The genetic landscape of polycystic kidney disease in Ireland. Eur J Hum Genet. 2021;29:827–838. doi: 10.1038/s41431-020-00806-5. PubMed DOI PMC

Cornec-Le Gall E., Alam A., Perrone R.D. Autosomal dominant polycystic kidney disease. Lancet. 2019;393:919–935. doi: 10.1016/S0140-6736(18)32782-X. PubMed DOI

Heyer C.M., Sundsbak J.L., Abebe K.Z., et al. Predicted mutation strength of nontruncating PKD1 mutations Aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016;27:2872–2884. doi: 10.1681/ASN.2015050583. PubMed DOI PMC

Senum S.R., Li Y.S.M., Benson K.A., et al. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am J Hum Genet. 2022;109:136–156. doi: 10.1016/j.ajhg.2021.11.016. PubMed DOI PMC

Lemoine H., Raud L., Foulquier F., et al. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis. Am J Hum Genet. 2022;109:1484–1499. doi: 10.1016/j.ajhg.2022.06.013. PubMed DOI PMC

Inker L.A., Eneanya N.D., Coresh J., et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737–1749. doi: 10.1056/NEJMoa2102953. PubMed DOI PMC

Levin A., Stevens P.E. Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 2014;85:49–61. doi: 10.1038/ki.2013.444. PubMed DOI

Vylet’al P., Kublova M., Kalbacova M., et al. Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int. 2006;70:1155–1169. doi: 10.1038/sj.ki.5001728. PubMed DOI

Zivna M., Hulkova H., Matignon M., et al. Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet. 2009;85:204–213. doi: 10.1016/j.ajhg.2009.07.010. PubMed DOI PMC

Blumenstiel B., DeFelice M., Birsoy O., et al. Development and validation of a mass spectrometry-based assay for the molecular diagnosis of mucin-1 kidney disease. J Mol Diagn. 2016;18:566–571. doi: 10.1016/j.jmoldx.2016.03.003. PubMed DOI

Zivna M., Kidd K., Pristoupilova A., et al. Noninvasive immunohistochemical diagnosis and novel MUC1 mutations causing autosomal dominant tubulointerstitial kidney disease. J Am Soc Nephrol. 2018;29:2418–2431. doi: 10.1681/ASN.2018020180. PubMed DOI PMC

Murray S.L., Dorman A., Benson K.A., et al. Utility of genomic testing after renal biopsy. Am J Nephrol. 2020;51:43–53. doi: 10.1159/000504869. PubMed DOI PMC

Elhassan E.A.E., Murray S.L., Connaughton D.M., et al. The utility of a genetic kidney disease clinic employing a broad range of genomic testing platforms: experience of the Irish Kidney Gene Project. J Nephrol. 2022;35:1655–1665. doi: 10.1007/s40620-021-01236-2. PubMed DOI PMC

Hartmannová H., Piherová L., Tauchmannová K., et al. Acadian variant of Fanconi syndrome is caused by mitochondrial respiratory chain complex I deficiency due to a non-coding mutation in complex I assembly factor NDUFAF6. Hum Mol Genet. 2016;25:4062–4079. doi: 10.1093/hmg/ddw245. PubMed DOI

Chang C.C., Chow C.C., Tellier L.C., Vattikuti S., Purcell S.M., Lee J.J. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience. 2015;4:7. doi: 10.1186/s13742-015-0047-8. PubMed DOI PMC

Gandini R., Reichenbach T., Tan T.C., Divne C. Structural basis for dolichylphosphate mannose biosynthesis. Nat Commun. 2017;8:120. doi: 10.1038/s41467-017-00187-2. PubMed DOI PMC

Landmann L. Deconvolution improves colocalization analysis of multiple fluorochromes in 3D confocal data sets more than filtering techniques. J Microsc. 2002;208:134–147. doi: 10.1046/j.1365-2818.2002.01068.x. PubMed DOI

Manders E.M.M., Verbeek F.J., Aten J.A. Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 1993;169:375–382. doi: 10.1111/j.1365-2818.1993.tb03313.x. PubMed DOI

Vylet’al P., Kidd K., Ainsworth H.C., et al. Plasma Mucin-1 (CA15-3) levels in autosomal dominant tubulointerstitial kidney disease due to MUC1 mutations. Am J Nephrol. 2021;52:378–387. doi: 10.1159/000515810. PubMed DOI PMC

Seta N., Barnier A., Hochedez F., Besnard M.A., Durand G. Diagnostic value of Western blotting in carbohydrate-deficient glycoprotein syndrome. Clin Chim Acta. 1996;254:131–140. doi: 10.1016/0009-8981(96)06379-6. PubMed DOI

Darebna P., Novak P., Kucera R., et al. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring. J Proteomics. 2017;153:44–52. doi: 10.1016/j.jprot.2016.09.004. PubMed DOI PMC

Rappsilber J., Mann M., Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007;2:1896–1906. doi: 10.1038/nprot.2007.261. PubMed DOI

Tyanova S., Temu T., Cox J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc. 2016;11:2301–2319. doi: 10.1038/nprot.2016.136. PubMed DOI

Cox J., Neuhauser N., Michalski A., Scheltema R.A., Olsen J.V., Mann M. Andromeda: A peptide search engine integrated into the MaxQuant environment. J Proteome Res. 2011;10:1794–1805. doi: 10.1021/pr101065j. PubMed DOI

Cox J., Hein M.Y., Luber C.A., Paron I., Nagaraj N., Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics. 2014;13:2513–2526. doi: 10.1074/mcp.M113.031591. PubMed DOI PMC

Perez-Riverol Y., Csordas A., Bai J., et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442–D450. doi: 10.1093/nar/gky1106. PubMed DOI PMC

Burda P., Aebi M. The dolichol pathway of N-linked glycosylation. Biochim Biophys Acta. 1999;1426:239–257. doi: 10.1016/s0304-4165(98)00127-5. PubMed DOI

Jagadeesh K.A., Wenger A.M., Berger M.J., et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48:1581–1586. doi: 10.1038/ng.3703. PubMed DOI

Lavu S., Vaughan L.E., Senum S.R., et al. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. JCI Insight. 2020;5 doi: 10.1172/jci.insight.138724. PubMed DOI PMC

Bruneel A., Cholet S., Tran N.T., Mai T.D., Fenaille F. CDG biochemical screening: where do we stand? Biochim Biophys Acta (BBA) Gen Subj. 2020;1864 doi: 10.1016/j.bbagen.2020.129652. PubMed DOI

Rule A.D., Sasiwimonphan K., Lieske J.C., Keddis M.T., Torres V.E., Vrtiska T.J. Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors. Am J Kidney Dis. 2012;59:611–618. doi: 10.1053/j.ajkd.2011.12.022. PubMed DOI PMC

Porath B., Gainullin V.G., Cornec-Le Gall E., et al. Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet. 2016;98:1193–1207. doi: 10.1016/j.ajhg.2016.05.004. PubMed DOI PMC

Al-Said J., Brumback M.A., Moghazi S., Baumgarten D.A., O’Neill W.C. Reduced renal function in patients with simple renal cysts. Kidney Int. 2004;65:2303–2308. doi: 10.1111/j.1523-1755.2004.00651.x. PubMed DOI

Dornan L.G., Simpson J.C. Rab6-mediated retrograde trafficking from the Golgi: the trouble with tubules. Small GTPases: GD, and J, C.S. 2023;14:26–44. doi: 10.1080/21541248.2023.2238330. PubMed DOI PMC

Kim W.K., Choi W., Deshar B., Kang S., Kim J. Golgi stress response: new insights into the pathogenesis and therapeutic targets of human diseases. Mol Cells. 2023;46:191–199. doi: 10.14348/molcells.2023.2152. PubMed DOI PMC

Dvela-Levitt M., Kost-Alimova M., Emani M., et al. Small molecule targets TMED9 and promotes lysosomal degradation to reverse proteinopathy. Cell. 2019;178:521–535.e23. doi: 10.1016/j.cell.2019.07.002. PubMed DOI

Zivna M., Kidd K.O., Baresova V., Hulkova H., Kmoch S., Bleyer AJ, Sr. Autosomal dominant tubulointerstitial kidney disease: a review. Am J Med Genet C. 2022;190:309–324. doi: 10.1002/ajmg.c.32008. PubMed DOI PMC

Cornec-Le Gall E., Olson R.J., Besse W., et al. Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease. Am J Hum Genet. 2018;102:832–844. doi: 10.1016/j.ajhg.2018.03.013. PubMed DOI PMC

Besse W., Chang A.R., Luo J.Z., et al. ALG9 mutation carriers develop kidney and liver cysts. J Am Soc Nephrol. 2019;30:2091–2102. doi: 10.1681/ASN.2019030298. PubMed DOI PMC